1. Home
  2. SUPN vs EVCM Comparison

SUPN vs EVCM Comparison

Compare SUPN & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • EVCM
  • Stock Information
  • Founded
  • SUPN 2005
  • EVCM 2006
  • Country
  • SUPN United States
  • EVCM United States
  • Employees
  • SUPN N/A
  • EVCM N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • EVCM EDP Services
  • Sector
  • SUPN Health Care
  • EVCM Technology
  • Exchange
  • SUPN Nasdaq
  • EVCM Nasdaq
  • Market Cap
  • SUPN 1.9B
  • EVCM 2.0B
  • IPO Year
  • SUPN 2012
  • EVCM 2021
  • Fundamental
  • Price
  • SUPN $34.70
  • EVCM $10.87
  • Analyst Decision
  • SUPN Hold
  • EVCM Buy
  • Analyst Count
  • SUPN 1
  • EVCM 11
  • Target Price
  • SUPN $36.00
  • EVCM $11.45
  • AVG Volume (30 Days)
  • SUPN 295.5K
  • EVCM 63.3K
  • Earning Date
  • SUPN 11-04-2024
  • EVCM 11-12-2024
  • Dividend Yield
  • SUPN N/A
  • EVCM N/A
  • EPS Growth
  • SUPN N/A
  • EVCM N/A
  • EPS
  • SUPN 0.08
  • EVCM N/A
  • Revenue
  • SUPN $630,163,000.00
  • EVCM $691,687,000.00
  • Revenue This Year
  • SUPN $4.01
  • EVCM $4.47
  • Revenue Next Year
  • SUPN $0.10
  • EVCM $5.08
  • P/E Ratio
  • SUPN $459.76
  • EVCM N/A
  • Revenue Growth
  • SUPN N/A
  • EVCM 6.23
  • 52 Week Low
  • SUPN $23.05
  • EVCM $6.22
  • 52 Week High
  • SUPN $35.56
  • EVCM $12.35
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 61.96
  • EVCM 61.04
  • Support Level
  • SUPN $33.73
  • EVCM $10.52
  • Resistance Level
  • SUPN $35.56
  • EVCM $10.84
  • Average True Range (ATR)
  • SUPN 0.84
  • EVCM 0.21
  • MACD
  • SUPN 0.04
  • EVCM 0.04
  • Stochastic Oscillator
  • SUPN 62.45
  • EVCM 90.62

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts..

Share on Social Networks: